TRZZX
Price
$63.54
Change
+$0.07 (+0.11%)
Updated
Jun 2 closing price
Net Assets
8.59B
WCMNX
Price
$14.98
Change
+$0.18 (+1.22%)
Updated
Jun 2 closing price
Net Assets
53.09M
Interact to see
Advertisement

TRZZX vs WCMNX

Header iconTRZZX vs WCMNX Comparison
Open Charts TRZZX vs WCMNXBanner chart's image
TRZZX vs WCMNX Comparison Chart in %
View a ticker or compare two or three
VS
TRZZX vs. WCMNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRZZX is a Buy and WCMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRZZX has more cash in the bank: 8.59B vs. WCMNX (53.1M). TRZZX pays higher dividends than WCMNX: TRZZX (0.66) vs WCMNX (0.00). TRZZX was incepted earlier than WCMNX: TRZZX (6 years) vs WCMNX (7 years). WCMNX (2.04) is less costly to investors than TRZZX (0.74). WCMNX is a more actively managed with annual turnover of: 89.00 vs. TRZZX (78.10). TRZZX has a lower initial minimum investment than WCMNX: TRZZX (0) vs WCMNX (1000). WCMNX annual gain was more profitable for investors over the last year : 25.42 vs. TRZZX (16.31). WCMNX return over 5 years is better than : -1.40 vs. TRZZX (-6.70).
TRZZXWCMNXTRZZX / WCMNX
Total Expense Ratio0.001.24-
Annual Report Gross Expense Ratio0.742.0436%
Fund Existence6 years7 years-
Gain YTD10.6919.225116%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.59B53.1M16,185%
Annual Yield % from dividends0.660.00-
Returns for 1 year16.3125.4264%
Returns for 3 years21.0531.2167%
Returns for 5 years-6.70-1.40479%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IILGX32.710.13
+0.40%
Thrivent Global Stock S
BLDRX9.740.01
+0.10%
BlackRock Managed Income K
RYENX313.96N/A
N/A
Rydex Energy A
FPACX45.31N/A
N/A
FPA Crescent
NSCCX43.02N/A
N/A
Nuveen Small-Cap Value Opps C